The share capital of Virbac amounts now to €10,488,325 and not €10,448,325 as announced. Focusing on animal health, from the beginningAt Virbac, we provide innovative solutions to ...
WESTLAKE, Texas, Jan. 7, 2025 /PRNewswire/ -- Virbac, a global leader in animal health, has collaborated with Emmyon, Inc., a ...
Virbac said that URSOLYX Soft Chews targets mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic ...
WESTLAKE, Texas, Jan. 7, 2025 /PRNewswire/ -- Virbac, a global leader in animal health, has collaborated with Emmyon, Inc., a biotechnology company specializing in skeletal muscle biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results